Oura Moves Toward a Major Public Listing

Oura has formally launched its initial public offering, setting the stage for one of the more closely watched listings in the smart-health technology market. The company plans to sell 50 million shares at between $40 and $44 each, targeting proceeds of as much as $2.2 billion and a fully diluted valuation of approximately $15.62 billion.

The company has applied to list on the Nasdaq Global Select Market under the ticker “OURA,” with trading expected to begin next week. Oura itself is offering 13.5 million shares, while existing shareholders are selling 36.5 million. Because most of the shares are being sold by existing investors, Oura will not receive proceeds from that portion of the offering.

Strong Growth Supports the IPO Case

Oura’s financial and membership growth provide a significant part of the investment story. The company sold approximately 3.6 million rings during the year through June 30, while revenue reached $1.21 billion during the nine months ended on that date. That represented roughly 74% growth compared with the corresponding period a year earlier.

The company also expects its paid membership base to reach approximately 5.7 million by the end of fiscal 2026, nearly twice the level recorded a year earlier. The combination of hardware sales and recurring membership revenue gives Oura a business model that extends beyond one-time device purchases.

Strategic Investors Show Interest

The IPO has also attracted indications of interest from major investors. Eli Lilly has signaled that it could purchase up to $100 million of Oura shares, while investment firm Dragoneer has expressed interest in acquiring as much as $300 million.

Goldman Sachs, Morgan Stanley and J.P. Morgan are serving as lead underwriters, with Allen & Company and Jefferies acting as joint lead book-running managers. The structure and level of institutional interest will be closely watched as Oura moves through the final stages of the offering.

Oura Enters the Market With Some Risks

The IPO follows a $900 million late-stage funding round in October that valued Oura at approximately $11 billion. Founded in Finland in 2013 and now headquartered in San Francisco, the company has built its business around a smart ring that tracks measurements including sleep, activity and heart health through a connected smartphone application.

However, the company is also facing a proposed class-action lawsuit filed in August alleging that its device does not measure sleep stages with the accuracy claimed in its marketing. Oura disputes the allegations and has said it intends to defend itself against the lawsuit.

A Challenging IPO Environment

Oura’s listing arrives as investors have become more selective across growth-oriented markets. Volatility surrounding technology investments, higher bond yields and uncertainty over the Federal Reserve’s interest-rate path have created a more difficult environment for new offerings.

That backdrop could make Oura’s valuation, recurring membership growth and ability to maintain rapid revenue expansion particularly important factors as investors assess the IPO.

What Investors May Watch Next

The key test for Oura will be whether its strong revenue and membership growth can justify the valuation targeted in the offering. Investors may focus on the pace of subscription expansion, demand for new ring products, competitive pressure, legal developments and the company’s ability to sustain growth as it transitions into the public markets.